For this purpose, non‐depleted and PTPRK‐depleted SW480/CD133 cells were treated with the indicated concentrations of oxaliplatin, which is commonly used in a standard chemotherapy for colon cancer patients. This evidence concerns the gene PROM1 and colonic neoplasm.